Patent · US Active

Methods for the treatment of uveitis with IL-1β binding antibodies

US9139646B2 · kind B2 · utility

6Cited by

31References

73Claims

0Family size

Assignee

XOMA (US) LLC · US

Inventors

Alan M. Solinger · Oakland, US
Ahmet Gül · İstanbul, TR

Key dates

Filing date	Sep 17, 2013
Grant date	Sep 22, 2015
Priority date	—
Expiry date	Sep 17, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1β binding molecules (e.g., IL-1β binding antibodies or binding fragment thereof).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.